Pfizer reports Q3 loss amid declining COVID-19 products sales
NEW YORK, Oct. 31 (Xinhua) -- U.S. drugmaker Pfizer reported Tuesday a loss of 2.4 billion U.S. dollars for the third quarter due to the continued declining sales of its COVID-19 vaccine and treatments.
Pfizer said its third-quarter revenue was 13.23 billion dollars, lower than expected, down 42 percent from a year ago.
The company's quarterly COVID-19 vaccine sales raked in 1.31 billion dollars, a drop o